Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Amneal Pharmaceuticals, Inc.

AMRX · Nasdaq · CIK 0001723128 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

23 Form 4 transaction lines observed in the same window
5 sales · 18 option, withholding, award, gift or other lines

Last qualifying purchase2021-12-17 · Patel Gautam · $210.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
BUCHI J KEVINDirector
○○○○
Kiely JohnDirector
○○▼
BOYER ANDREW SExecutive Vice President
○○
Daly Jason B.EVP, Chief Legal Officer
▼▼
Autor Deborah M.Director
○▼
Patel GautamDirector
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 8 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2021-12-17 · Patel Gautam.

Recent Form 4 activity

0Purchases
7Sales
72Other Form 4 lines
29SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING5 sale line(s) · context only
OTHER18 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+12.4%
3M
+20.0%
6M
+62.7%
12M
—

Volatility & liquidity

Volatility
35.8%
Beta
1.24
Avg daily value
USD 43.6M

Valuation

Market cap
USD 7.1B
P/E
42.3×

Fundamentals

Profit margin
2.4%
ROE
613.0%
Industry
Drug Manufacturers—Specialty & Generic

Market data

Price data up to: 2026-10-03 · Price source: OpenBB/yfinance · From SEC filings: Profit margin · Fiscal year ended: 2025-12-31 · From Yahoo Finance: Market cap, P/E, ROE · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
11,278,967
Previous report
11,289,778
Avg daily volume
3,689,288
Days to cover
3.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2021-12-17Patel GautamPurchase (P)Class A Common Stock50,000USD 4.21USD 210,500SEC filing ↗
2021-12-16Patel Chirag K.Purchase (P)Class A Common Stock50,000USD 4.25USD 212,500SEC filing ↗
2021-12-16Patel ChintuPurchase (P)Class A Common Stock50,000USD 4.25USD 212,500SEC filing ↗
2021-12-15Patel Chirag K.Purchase (P)Class A Common Stock100,000USD 4.13USD 413,000SEC filing ↗
2021-12-15Patel ChintuPurchase (P)Class A Common Stock100,000USD 4.13USD 413,000SEC filing ↗
2020-05-19Kiely JohnPurchase (P)Class A Common Stock10,000USD 4.40USD 44,000SEC filing ↗
2020-05-15George Jeffrey P.Purchase (P)Class A Common Stock23,810USD 4.16USD 99,050SEC filing ↗
2020-03-18MEISTER PAUL MPurchase (P)Class A Common Stock204,210USD 2.71USD 553,409SEC filing ↗
2020-03-17MEISTER PAUL MPurchase (P)Class A Common Stock149,439USD 2.79USD 416,935SEC filing ↗
2020-03-10Patel Chirag K.Purchase (P)Class A Common Stock100,000USD 3.09USD 309,000SEC filing ↗
2020-03-10Patel ChintuPurchase (P)Class A Common Stock100,000USD 3.09USD 309,000SEC filing ↗
2020-03-04Patel Chirag K.Purchase (P)Class A Common Stock58,938USD 3.97USD 233,984SEC filing ↗
2020-03-04Patel ChintuPurchase (P)Class A Common Stock58,765USD 3.97USD 233,297SEC filing ↗
2020-03-03Patel GautamPurchase (P)Class A Common Stock117,889USD 3.94USD 464,483SEC filing ↗
2020-03-03Patel Chirag K.Purchase (P)Class A Common Stock156,421USD 3.88USD 606,913SEC filing ↗

Form 4 evidence

79 transaction lines in the latest 365-day window; 376 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-17BUCHI J KEVINGift (G)Class A Common Stock20,445USD 0.00USD 0SEC filing ↗
2026-09-11BUCHI J KEVINOption exercise / conversion (M)Class A Common Stock20,445USD 14.45USD 295,430SEC filing ↗
2026-09-01BOYER ANDREW SGift (G)Class A Common Stock80,000USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-17BUCHI J KEVINGift (G)Class A Common Stock20,445USD 0.00USD 0SEC filing ↗
2026-09-11BUCHI J KEVINOption exercise / conversion (M)Class A Common Stock20,445USD 14.45USD 295,430SEC filing ↗
2026-09-01BOYER ANDREW SGift (G)Class A Common Stock80,000USD 0.00USD 0SEC filing ↗
2026-08-21BOYER ANDREW SGift (G)Class A Common Stock152,426USD 0.00USD 0SEC filing ↗
2026-08-13Kiely JohnSale (S)Class A Common Stock50,000USD 17.64USD 882,000SEC filing ↗
2026-08-13Kiely JohnGift (G)Class A Common Stock10,000USD 0.00USD 0SEC filing ↗
2026-08-12Shah NikitaSale (S)Class A Common Stock146,403USD 17.51USD 2,563,517SEC filing ↗
2026-08-12Daly Jason B.Sale (S)Class A Common Stock210,000USD 17.40USD 3,654,000SEC filing ↗
2026-08-11Daly Jason B.Sale (S)Class A Common Stock6,613USD 17.70USD 117,050SEC filing ↗
2026-08-11BUCHI J KEVINOption exercise / conversion (M)Class A Common Stock168,573USD 17.18USD 2,896,084SEC filing ↗
2026-08-10Patel Tushar BhikhubhaiAward / grant (A)Class A Common Stock12,763,469USD —USD —SEC filing ↗
2026-08-10Patel GautamAward / grant (A)Class A Common Stock283,632USD —USD —SEC filing ↗
2026-08-10Patel Chirag K.Award / grant (A)Class A Common Stock6,381,734USD —USD —SEC filing ↗
2026-08-10Patel ChintuAward / grant (A)Class A Common Stock6,381,734USD —USD —SEC filing ↗
2026-05-11Autor Deborah M.Sale (S)Class A Common Stock34,819USD 12.94USD 450,558SEC filing ↗
2026-05-07Yanai ShlomoOption exercise / conversion (M)Class A Common Stock34,819USD —USD —SEC filing ↗
2026-05-07Patel GautamOption exercise / conversion (M)Class A Common Stock34,819USD —USD —SEC filing ↗
2026-05-07Nark Ted COption exercise / conversion (M)Class A Common Stock34,819USD —USD —SEC filing ↗
2026-05-07MEISTER PAUL MOption exercise / conversion (M)Class A Common Stock48,747USD —USD —SEC filing ↗
2026-05-07Kiely JohnOption exercise / conversion (M)Class A Common Stock34,819USD —USD —SEC filing ↗
2026-05-07George Jeffrey P.Option exercise / conversion (M)Class A Common Stock34,819USD —USD —SEC filing ↗
2026-05-07BUCHI J KEVINOption exercise / conversion (M)Class A Common Stock34,819USD —USD —SEC filing ↗
2026-05-07Autor Deborah M.Option exercise / conversion (M)Class A Common Stock34,819USD —USD —SEC filing ↗
2026-03-04Shah NikitaOption exercise / conversion (M)Class A Common Stock35,880USD —USD —SEC filing ↗
2026-03-04Shah NikitaTax withholding (F)Class A Common Stock17,976USD 13.30USD 239,081SEC filing ↗
2026-03-04Patel Chirag K.Option exercise / conversion (M)Class A Common Stock92,593USD —USD —SEC filing ↗
2026-03-04Patel Chirag K.Tax withholding (F)Class A Common Stock37,825USD 13.30USD 503,072SEC filing ↗
2026-03-04Patel ChintuOption exercise / conversion (M)Class A Common Stock92,593USD —USD —SEC filing ↗
2026-03-04Patel ChintuTax withholding (F)Class A Common Stock28,983USD 13.30USD 385,474SEC filing ↗
2026-03-04Konidaris TasosOption exercise / conversion (M)Class A Common Stock43,982USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerAMRX
CIK0001723128
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history376 transaction lines from 2020-01-03 to 2026-09-17
20 P purchase lines · 51 S sale lines · 305 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.